In summary, genetic or pharmacological inhibition of ASGR1 exerts dual biological functions to halt hypercholesterolemia by inhibiting cholesterol synthesis while promoting cholesterol efflux and excretion from the body. This evidence concerns the gene ASGR1 and familial hypercholesterolemia.